The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status. Biomol Biomed [Internet]. 2024 Mar. 11 [cited 2024 May 14];24(2):256–261. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9868